GTCSX
Price
$31.13
Change
+$0.02 (+0.06%)
Updated
Feb 3 closing price
Net Assets
994.84M
VSCIX
Price
$130.42
Change
+$7.87 (+6.42%)
Updated
Feb 3 closing price
Net Assets
162.31B
Interact to see
Advertisement

GTCSX vs VSCIX

Header iconGTCSX vs VSCIX Comparison
Open Charts GTCSX vs VSCIXBanner chart's image
Glenmede Small Cap Equity Adv
Price$31.13
Change+$0.02 (+0.06%)
VolumeN/A
Net Assets994.84M
Vanguard Small Cap Index I
Price$130.42
Change+$7.87 (+6.42%)
VolumeN/A
Net Assets162.31B
GTCSX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
GTCSX vs. VSCIX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTCSX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 162B vs. GTCSX (995M). VSCIX pays higher dividends than GTCSX: VSCIX (1.28) vs GTCSX (0.43). GTCSX was incepted earlier than VSCIX: GTCSX (35 years) vs VSCIX (29 years). GTCSX (0.94) is less costly to investors than VSCIX (0.04). GTCSX is a more actively managed with annual turnover of: 92.00 vs. VSCIX (13.00). GTCSX has a lower initial minimum investment than VSCIX: GTCSX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 10.72 vs. GTCSX (-5.41). VSCIX return over 5 years is better than : 31.94 vs. GTCSX (-0.61).
GTCSXVSCIXGTCSX / VSCIX
Total Expense Ratio0.940.042,350%
Annual Report Gross Expense Ratio0.940.042,350%
Fund Existence35 years29 years-
Gain YTD4.8505.53588%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets995M162B1%
Annual Yield % from dividends0.431.2833%
Returns for 1 year-5.4110.72-50%
Returns for 3 years-3.6033.12-11%
Returns for 5 years-0.6131.94-2%
Returns for 10 years45.09186.9424%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TARS66.860.93
+1.41%
Tarsus Pharmaceuticals
OMEX1.900.01
+0.53%
Odyssey Marine Exploration
YUMC50.740.16
+0.32%
Yum China Holdings
CEPF10.46-0.01
-0.10%
Cantor Equity Partners IV Inc.
PPBT0.59-0.02
-2.79%
Purple Biotech Ltd